Resources
AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals
AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals Deals mark an important...
Read MoreWe must fix the business model for new antibiotics
AMR Action Fund CEO Henry Skinner and BIO CEO Dr. Michelle McMurry-Heath co-authored a Fortune op-ed on policy solutions to the...
Pressure grows for market reforms to help tackle ‘silent pandemic’ of AMR
The Financial Times reported on the challenges of bringing new antibiotics to market and the growing political will to remedy the...
More Investment Sorely Needed to Combat Antimicrobial Resistance
MedPage today reported on the struggles that some biotechs face as they develop antibiotics. The article featured news from the...
Antibiotic resistance in the patient with cancer
The current focus on the coronavirus disease 2019 (COVID-19) pandemic means a lack of attention to other health challenges, such as antimicrobial resis- tance.
Legislation Aims to Jump Start Antibiotic Development
Before joining the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), Duffy served as executive vice president and chief scientific officer at Melinta Therapeutics, a developer of new antibiotics.
Drug-resistant Infections Led to $1.9 Billion in Health Care Costs
Superbugs that are resistant to existing antibiotics already take an enormous toll on health-care systems around the world.
Governments fall behind in race to stem antimicrobial resistance
When drugmaker AstraZeneca closed down its research and development centre in Bangalore six years ago, some of the local scientists managed to find new jobs at a nearby biotech start-up. Since then, they have been working to tackle a problem which is causing concern among doctors in India and around the world: increasing resistance to antibiotics undermining treatments.
A research and development fund for new treatments for bacteria...
The current focus on the coronavirus disease 2019 (COVID-19) pandemic means a lack of attention to other health challenges, such as antimicrobial resis- tance.
